Influence of borneol on primary mice oral fibroblasts: a penetration enhancer may be used in oral submucous fibrosis

被引:58
|
作者
Dai, Jian-Ping [1 ]
Chen, Jun [1 ]
Bei, Yu-Fei [1 ]
Han, Bang-Xing [1 ]
Wang, Sheng [1 ]
机构
[1] Jiangsu Univ, Sch Food & Bioengn, Zhenjiang 212013, Jiangsu, Peoples R China
关键词
matrix metalloproteinases; oral mucosa; submucous fibrosis; IN-VITRO; PROLIFERATION; MANAGEMENT; LYCOPENE; EFFICACY; TAIWAN;
D O I
10.1111/j.1600-0714.2008.00738.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Borneol, a widely used food and cosmetics additive, has analgesic, anti-inflammatory, antibacterial and penetration enhancing effects. We try to use it as a penetration enhancer for a formula which we have used to treat oral submucous fibrosis (OSF). To assess its safety, we investigate its effects on primary mice oral fibroblasts. Primary mice oral fibroblasts were cultured, the effects of borneol on fibroblasts proliferation, cytotoxicity, collagen production, matrix metalloproteinases-2,9 (MMP-2,9) activities and tissue inhibitors of metalloproteinase 1 (TIMP-1) production were tested by methyl thiazolyl tetrazolium assay, lactic dehydrogenase activity assay, chloramine T method, gelatin zymography and enzyme-linked immunosorbent assay, respectively. Borneol, from 18.75 to 300 mu g/ml, could significantly (P < 0.05) decrease the growth of fibroblasts and very significantly (P < 0.01) inhibit collagen production in a concentration dependant manner. From 18.75 to 150 mu g/ml, borneol had no cytotoxicity on mice oral fibroblasts. Moreover borneol could significantly (P < 0.05) decrease MMP-2 activity, and very significantly (P < 0.01) inhibit TIMP-1 production. This study indicates that borneol has anti-fibrosis activity and the mechanism may partly be relevant to its inhibiting effects on fibroblasts mitosis, collagen and TIMP-1 production. It can be safely used as a penetration enhancer for our formula to treat OSF.
引用
收藏
页码:276 / 281
页数:6
相关论文
共 5 条
  • [1] Copper stimulates human oral fibroblasts in vitro:: a role in the pathogenesis of oral submucous fibrosis
    Trivedy, C
    Meghji, S
    Warnakulasuriya, KAAS
    Johnson, NW
    Harris, M
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2001, 30 (08) : 465 - 470
  • [2] Phenotypic Expression of Oral Fibroblasts Derived from Oral Submucous Fibrosis: An Assay through Cell Culture
    Banerjee, Abhishek
    Mampilly, Mathew O.
    Kamath, V. V.
    Athreya, Vijayaraghavan
    Kotrashetti, Vijayalakshmi
    Srivastava, Kumar Chandan
    Shrivastava, Deepti
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2021, 13 (06): : S1234 - S1239
  • [3] Longitudinal outcomes of trismus release with free-flap reconstruction in primary and secondary oral submucous fibrosis-related trismus
    Chen, Jyh -Kwei
    Kao, Wen -Hsiang
    Huang, Pin -Hsuan
    Tsao, Chung -Kan
    Nee, Tzer -En
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2024, 92 : 26 - 32
  • [4] Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis
    Chang, YC
    Yang, SF
    Tai, KW
    Chou, MY
    Hsieh, YS
    ORAL ONCOLOGY, 2002, 38 (02): : 195 - 200
  • [5] LINC00084/miR-204/ZEB1 Axis Mediates Myofibroblastic Differentiation Activity in Fibrotic Buccal Mucosa Fibroblasts: Therapeutic Target for Oral Submucous Fibrosis
    Lee, Yu-Hsien
    Liao, Yi-Wen
    Lu, Ming-Yi
    Hsieh, Pei-Ling
    Yu, Cheng-Chia
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):